NJ Senator Introduces Bill That Could Federally Legalize Weed

A new bill introduced by New Jersey senator Cory Booker aims to do more than remove cannabis from the Schedule I Drug list — it would remove cannabis from the Scheduled Substances List entirely.

New Jersey Senator Cory Booker (D) recently introduced the best cannabis bill ever seen on Capitol Hill — The Marijuana Justice Act of 2017, which covers a plethora of cannabis issues, from federal scheduling to the disproportionate arrest rates people of color face under current policies.

If passed, the Marijuana Justice Act would remove cannabis from the list of scheduled substances, the magnitude of which is can’t possibly be overstated; it would make cannabis legal at the federal level. States would be encouraged (with federal funding) to make their policies match the new law of the land.

Read more at Cannabis Now

DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise

The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … under medical supervision.”

The agency has long contended that CBD, along with all organic cannabinoids, is — by default — a schedule I controlled substance because it is a naturally occurring component of the cannabis plant. (This position is similarly held by both the NIDA and the FDA.) Nonetheless, a growing body of science undermines the notion that CBD meets any of the criteria necessary for such classification.

Specifically, clinical trial data finds that CBD consumption is “safe,” “non-toxic,” and “well tolerated” in human volunteers. Even the director of the US National Institute on Drug Abuse acknowledges that CBD is “not mind-altering” and that it “appears to be a safe drug with no addictive effects.”

Read more at NORML

Left Behind by Clemency

What’s beef? Beef is when a rap video means the difference between a four-year sentence and 20 to life as a “cannabis kingpin.”

Jane Scarmazzo isn’t positive when her younger son started smoking pot, but she knows for sure how she found out about it.

Luke was in his early 20s, a few years out of high school and working with his father Nick Scarmazzo — a union carpenter — on bridges and overpasses in the San Francisco Bay Area.

Read more at Cannabis Now

END 4/20 SHAME: An Oncology Nurse’s Struggle

What if there was a medicine that could help millions of people, but doctors refused to or couldn’t prescribe the drug—you’d be furious, right? Well, that’s exactly what we’re fighting when it comes to cannabis.

Modern research suggests that cannabis is a valuable medicine that can be used in the treatment of a wide range of clinical applications, including pain relief, nausea, glaucoma and movement disorders. According to the National Institute on Drug Abuse, recent animal studies have shown that marijuana extracts may help kill certain cancer cells and reduce the size of others. And evidence from one study indicates that purified, whole-plant cannabis can slow the growth of a serious type of brain tumor. It’s also been shown to ease symptoms for patients suffering from HIV, AIDS, dementia and cancer.

There’s just one problem, according to Sanjay Gupta’s documentary, WEED: only six percent of medical studies have investigated the potential benefits of cannabis, rather than its harms. This has made the legalization of medicinal cannabis an uphill battle, one that Evan Christenson, an oncology nurse with twelve years of experience, knows intimately.

Read more at Dope Magazine

DEA Order Places Six ‘Spice’ Ingredients on Schedule I

BREAKING: A temporary scheduling order from the DEA has placed six more synthetic cannabinoids found in “spice” and “K2” on Schedule I. Banning these dangerous blends of artificial chemicals and inert plant matter (dishonestly sold as a legal alternatives to natural cannabis) is tricky because manufacturers are always changing their formulas.

The administrator of the Drug Enforcement Administration is issuing this temporary scheduling order making six synthetic cannabinoids used as the active ingredients in fake pot substances like “K2” and “spice” Schedule I narcotics.

The list of synthetic cannabinoids now considered to be Schedule I narcotics with no medical value now includes the following additions: 5F–ADB, 5F–AMB, 5F–APINACA, ADB–FUBINACA, MDMB–CHMICA and MDMB–FUBINACA. These chemicals join several others the agency has rescheduled using the same mechanism over the past few years.

Read more at Cannabis Now

Big Pharma Gets Green Light

Guess who benefits when Uncle Sam opens the research weed supply chain?

Cannabis is still highly dangerous and has no place in modern medicine, according to the U.S. government – who still wants a bigger and better supply of the troubled stuff on hand anyway, just in case.

And Uncle Sam wants you – yes, you – to try and grow some research-grade cannabis for your country. But good luck with that. It won’t be easy.

Read More